Orlandi P A, Critchley D R, Fishman P H
Membrane Biochemistry Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892.
Biochemistry. 1994 Nov 1;33(43):12886-95. doi: 10.1021/bi00209a021.
The E. coli type I heat-labile enterotoxin (LT-I) shares considerable functional, structural, and immunological homology with cholera toxin (CT). Although the ganglioside GM1 is the sole receptor for CT, LT-I also appears to utilize additional, unique receptors on intestinal cells not recognized by CT. We characterized this second class of LT-I receptors using the human intestinal epithelial cell line, CaCo-2. CaCo-2 cells bound 8-fold more LT-I than CT, and some of these additional LT-I receptors appeared to be functional, as CT-B only partially inhibited LT-I activity at concentrations that completely inhibited CT activity. Membranes from unlabeled or [3H]galactose-labeled cells were incubated with toxin B subunits and extracted with Triton X-100, and the solubilized toxin B-receptor complexes were immunoabsorbed with anti-B bound to protein A-Sepharose. When organic extracts of the complexes were separated by thin-layer chromatography and overlayed with [125I]toxin, both toxins were found to bind only GM1. Separation of the complexes from [3H]galactose-labeled membranes by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed a series of galactoproteins specifically recognized by LT-I but not by CT. Similar proteins were detected on Western blots probed with [125I]toxin. LT-I activity on intact cells and binding to membranes and the above galactoproteins were enhanced by neuraminidase treatment even in the presence of CT-B. beta-1,4-Galactosidase and endo-beta-1,4-galactosidase, but not beta-1,3-galactosidase, significantly reduced LT-I binding. LT-I binding to fetuin and transferrin exhibited a similar glycosidase sensitivity.(ABSTRACT TRUNCATED AT 250 WORDS)
大肠杆菌I型不耐热肠毒素(LT-I)与霍乱毒素(CT)在功能、结构和免疫学上有相当大的同源性。虽然神经节苷脂GM1是CT的唯一受体,但LT-I似乎还利用了CT未识别的肠道细胞上的其他独特受体。我们使用人肠上皮细胞系CaCo-2对这类第二种LT-I受体进行了表征。CaCo-2细胞结合的LT-I比CT多8倍,其中一些额外的LT-I受体似乎具有功能,因为在完全抑制CT活性的浓度下,CT-B仅部分抑制LT-I活性。将未标记或[3H]半乳糖标记细胞的膜与毒素B亚基孵育,并用Triton X-100提取,然后将溶解的毒素B-受体复合物用与蛋白A-琼脂糖结合的抗B进行免疫吸附。当复合物的有机提取物通过薄层色谱分离并用[125I]毒素覆盖时,发现两种毒素都只与GM1结合。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳从[3H]半乳糖标记的膜中分离复合物,揭示了一系列被LT-I而非CT特异性识别的半乳糖蛋白。在用[125I]毒素探测的Western印迹上检测到了类似的蛋白质。即使存在CT-B,神经氨酸酶处理也会增强完整细胞上的LT-I活性以及与膜和上述半乳糖蛋白的结合。β-1,4-半乳糖苷酶和内切β-1,4-半乳糖苷酶而非β-1,3-半乳糖苷酶显著降低LT-I的结合。LT-I与胎球蛋白和转铁蛋白的结合表现出类似的糖苷酶敏感性。(摘要截断于250字)